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Although many aspects of the regulation of acid secretion at the cellular level
among different species remains controversial, certain concepts have emerged
that span the differences between species, model systems and investigators. The
paracrine, endocrine, neural and autocrine pathways mediate acid secretion by
acting both directly on the parietal cell and indirectly via modulation ofmucos-
al paracrine cell function. Studies with cells isolated from the acid secreting
canine oxyntic mucosa indicate that gastrin and cholinergic receptors are pre-
sent on parietal cells, somatostatin cells, and the histamine-enterochromaffin-
like cell (ECL). Subtypes of these receptors are clearly important; the gastrin
receptor on the ECL cell and parietal cell are "B" type CCK/gastrin receptors,
whereas the receptor on the somatostatin cell is an A type CCK receptor. From
the vantage point of studies in the canine oxyntic mucosa, the challenge is no
longer to determine whether parietal, histamine or somatostatin cells have gas-
trin or muscarinic receptors but to establish the physiologic relevance of the
specific actions (secretory, trophic ordifferentiative) ofthese receptor subtypes.
Furthermore, the mechanisms integrating these paracrine, exocrine and neural
elements require elucidation.
INTRODUCTION
Although controversy has surrounded the cellularmechanisms and receptors account-
ing for the actions and interactions on secretatogogues on acid secretion over the last sev-
eral decades, considerable agreement has begun to emerge regarding the basic elements of
this regulation. The most controversial element has been the localization and mechanisms
ofaction ofgastrin and acetylcholine on acid secretion. Code hypothesized that histamine
was the final common chemostimulator of the parietal cell [1] for the actions of acetyl-
choline and gastrin. He postulated that receptors for these chemostransmitters resided on
gastric histamine-containing cells, not on parietal cells.Although this model accounted for
the ability ofhistamine H2-receptor antagonists to block the acid-secretory response to all
stimuli, it did not explain inhibition by anticholinergic agents of the response to gastrin.
Grossman proposed an alternate hypothesis [2] that the parietal cell possessed separate
and specific receptors for histamine, gastrin and acetylcholine, with potentiating interac-
tions among the secretagogues at the parietal cell itself. The controversy centered about
whether gastrin and acetylcholine acted in parallel with histamine on the parietal cell or
acted in series, with the final effector at theparietal cell being histamine.Aftermany years
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of controversy, it is now clear that both answers are correct, but the physiological rele-
vance ofeach ofthe redundant receptors present on several cell types remains to be deter-
mined.
COMPLEXITIES OF THE REGULATORY PATHWAYS
Several elements have contributed to the difficulty encountered in resolving these
questions. These regulatory mechanisms involve stimulatory and inhibitory pathways.
Furthermore, regulatory transmitters for several of these elements are in the vicinity or
delivered to the parietal and paracrine cells in amounts sufficient to exert control over
function in the basal state. In vivo, specific receptor antagonists, or occasionally mono-
clonal antibodies, have held the key to revealing the physiologic importance of specific
receptors, such as the H2 histamine receptor or the type Acholecystokinin (CCK)b recep-
tor. The role of histamine in the regulation of acid secretion was debated until the H2
receptor antagonists were shown to block all forms of acid secretion. Specific CCK type
Areceptor antagonists enhance the acid secretory response to CCK, indicating the impor-
tance ofinhibitory pathways mediated by these receptors. Definition ofthe specific path-
ways and receptor localization for neural input have been difficult to quantify and define
because these pathways impinge on numerous specific cell types, because transmitter out-
put cannot be measured and because specific pharmacologic tools are not yet available to
unravel these overlapping atid redundant receptors subtypes.
THE IN VITRO APPROACH
Removal of the parietal and paracrine cells from the influences ofthese endogenous
stimulants represents a major advantage of in vitro studies. With isolated cells or glands,
cell function can be directly monitored and stimulants added alone or in combination to
assess the specificity ofreceptors and potential mechanisms for secretagogue interdepen-
dence. Another major advantage ofisolated cell studies is the potential forcell separation.
Gastric mucosa represents a complex mixture ofcell types so that enrichment of various
subpopulations becomes essential for certain studies, such as localization of receptors or
characterization ofcell activation mechanisms.
AMODEL FOR REGULATORY CONTROL
OF PARACRINE AND EXOCRINE ELEMENTS
Isolated cell systems have proven useful for studying the receptors mediating secre-
tion because they allow the functional response on individual elements to be assessed in
the absence of intrinsic regulatory input. A model for the major pathways and cell types
mediating secretory function in the oxyntic mucosa is depicted in Figure 1. This model
illustrates the major stimulatory pathways, with parietal cells receiving paracrine (hista-
mine), neural (acetylcholine) and endocrine (gastrin) input; although the existence of
these receptors is clear, only the H2 histamine receptor stands unchallenged as the recep-
tor mediating the acid secretory response to histamine. Histamine-ECL cells receive
endocrine (gastrin) and neural (acetylcholine) input [3]. The somatostatin cell is the major
mediator ofparacrine inhibition in the oxyntic mucosa, receiving endocrine input primar-
ily via CCK/A receptors. Neural input to the somatostatin cell mediated by acetylcholine
acting at muscarinic receptors serves to inhibit somatostatin release, thereby enhancing
the acid secretory response. Somatostatin, in turn, appears to primarily exert paracrine
down-regulation of histamine release from ECL cells, although other targets for somato-
statin action may be important. The pathways regulating acid secretion, therefore, con-
verge at several sites, including parietal, histamine-ECL and somatostatin cells. Ofuncer-
tain physiologic importance are the oxyntic mucosal mast cells, which contain sufficient
histamine in close proximity to parietal cells to markedly impact secretory function; the
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Figure 1.Amodel for regulation ofacid secretory function. The pathways regulating acid secre-
tion provide input both to the parietal cell and to stimulatory (histamine-ECL) and inhibitor
(somatostatin) paracrine cells. Neural input provides critical integration.
physiology ofhistamine release from oxyntic mucosal mast cells is unknown. Many other
cell types in the lamina propria, such as macrophages, may also exert control ofmucosal
cell function, but details remain unknown.
THE INTERACTIONS BETWEEN PATHWAYS
Mirroring the redundancy of the pathways regulating acid secretion, interactions
between pathways occur via several mechanisms. The histamine dependency ofcholiner-
gic and gastrin action in partreflects cholinergic andgastrin induction ofhistamine release
from ECLcells. However, this mechanism would not account for the enhancement ofgas-
trin or cholinergic action by added histamine, which can be demonstrated in vivo and in
in vitro studies with parietal cells. Potentiating interactions at the parietal cell itself are
also hypothesized to account for a component of the interdependency between secreta-
gogues. Other interactions, such as cholinergic-gastrin interdependency, may reflect the
summation of actions on different cell types: cholinergic input enhances release ofhista-
mine, stimulates the parietal cell and inhibits release of the paracrine mediator somato-
statin; therefore, each ofthese actions would serve to enhance gastrin stimulation ofacid
secretion. Aprimary element in this interaction may be reduced somatostatin inhibition of
gastrin-induced histamine release. In contrast, with the administration of antimuscarinic
agents, stimulation by gastrin might be reduced by withdrawal of the additive effects of
muscarinic input at parietal and histamine cells and by removal of cholinergic inhibition
of somatostatin release. However, the physiological importance of the integration of
paracrine inputby neural mechanisms remains speculative and has not been tested in vivo.
THE PHYSIOLOGIC RELEVANCE OF RECEPTORS
ON PARIETALAND ECL CELLS
Studies utilizing isolated oxyntic mucosal cells clearly indicate that gastrin and
acetylcholine receptors are present on several cell types, including parietal cells, somato-
statin cells, and histamine-containing endocrine cells. However, the contribution to con-
trol ofsecretion, cell replication and differentiation ofeach ofthese different receptor sites
remains uncertain.
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ECL cell receptors
The ability of gastrin to induce histamine release from gastric mucosal endocrine
cells has been established [4-8]. In rabbit and rat gastric mucosa, the magnitude of hista-
mine release by gastrin appears to be sufficient to stimulate parietal cell function, sup-
porting the physiologic importance of this indirect limb of gastrin action for acid secreto-
ry regulation [7, 9]. Histamine-ECL cells from the oxyntic mucosa from several species
respond well to gastrin in vitro, in contrast to the definite, but weak and variable, respons-
es of the parietal cell to gastrin. Therefore, is appears likely that gastrin receptors on his-
tamine-ECL cells mediate gastrin action on acid secretion.
Parietal cell receptors
There are, however, several lines ofevidence indicating that functional gastrin recep-
tors are also present on parietal cells [3]. The potentiating interactions observed between
gastrin and histamine or post-receptors activators of the cyclic AMP pathway cannot be
explained without hypothesizing aparietal cell gastrin receptor. Furthermore, in vivo, gas-
trin receptors appears to exert effects on acid secretion that are independent of histamine
H2 receptors. For example, Michelangeli and Ruiz found that, in the presence of cimeti-
dine, dibutryl-cAMP enhanced gastrin stimulation of acid secretion [10], arguing for
direct gastrin action of the parietal cell, with interactions via post-receptor cyclic AMP
mechanisms. Black has also found direct interactions between dibutyryl cyclic AMP and
cholinergic stimulation at parietal cell receptors [11]. In neonatal rats, Ackerman [12]
found a dissociation between gastrin- and histamine-stimulated acid secretion; the acid
secretory response to exogenous pentagastrin was detectable at 14 days of age, whereas
response to exogenous histamine did not become detectable until day 19 to 22.
Furthermore, the response to gastrin at 14 days of age was not blocked by H2 blockers,
suggesting an direct component ofgastrin action in vivo independent ofhistamine. Taken
together, the available data strongly indicate thatfunctional gastrin receptors exist on pari-
etal cells; however, data do not indicate the proportion of the acid secretory response to
gastrin that reflects interaction with these parietal cell gastrin receptors.
It is possible that gastrin stimulation of the parietal cell and induction of histamine
release are both physiologically relevant effects, but other functions may be served by
these receptors in addition to the acute regulation of acid secretory mechanisms. The gas-
trin effect on either of these cell types may reflect trophic actions and/or induction and
maintenance of cell differentiation. For example, gastrin has been reported to induce
expression of theH+/K+-ATPase messenger RNA in parietal cells [13] and to induce his-
tamine decarboxylase activity in the rat oxyntic ECL [14]. Approaches are needed to
determine the physiologic importance of these differentiative effects in comparison to the
effects of gastrin that stimulate acid secretion via either induction of histamine release or
direct activation of the parietal cell.
INHIBITORY MODULATORS
Several inhibitory elements are also responsive to input from paracrine, endocrine
and neural input. Using immunoneutralization, somatostatin has been shown to exert
paracrine inhibitory effects in vivo, ex vivo and in tissue culture systems, leaving no ques-
tion that the inhibitory effects of somatostatin are physiologically relevant. Studies with
ex vivo preparations provided evidence that oxyntic somatostatin plays arole in acid feed-
back inhibition of acid secretion [15]. Although somatostatin inhibits gastrin and parietal
cells, inhibition of oxyntic mucosal histamine release is a sensitive and dramatic effect of
somatostatin. The major effect of somatostatin action may be inhibition of histamine
release; this conclusion is consistent with the in vivo findings that somatostatin more
effectively inhibits gastrin than histamine stimulation.
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The physiologic importance of the inhibitory paracrine circuit mediated by somato-
statin has been supported by studies involving gastrin/CCK receptor family subtypes.
CCK typeAreceptors on the oxyntic mucosal somatostatin cell exert inhibitory effects on
acid secretion. In the dog, the poor efficacy ofCCK stimulating acid secretion, despite an
efficacy equal to gastrin at both parietal and histamine-ECL cell receptors, appears to
reflect greater activation of the inhibitory circuit by CCK, since selective blockade of
CCK type A receptors markedly enhances the acid secretory response and attenuates
release of somatostatin in response to CCK. It appears that gastrin may also induce
somatostatin release via type B receptors on somatostatin cells, but the physiological rel-
evance of these receptors remains uncertain.
INTEGRATION OF INHIBITORYAND STIMULATORY PATHWAYS
With the opposing stimulatory and inhibitory actions ofregulators such as gastrin and
CCK, integrating mechanisms are critical, but not yet well understood. As noted above,
muscarinic agents inhibit somatostatin release from somatostatin cells from canine oxyn-
tic mucosa. Cholinergic input, therefore, exerts acid stimulatory effects via direct stimu-
lation ofthe parietal cell, induction ofhistamine release and suppression ofthe inhibitory
circuit mediated by somatostatin.
RECEPIORS ON IMMUNE CELLS
A recent report from Mezey and Palkovits [16] localizes mRNA for histamine, gas-
trin, muscarinic and dopamine receptors by in situ hybridization to immunocytes in gas-
tric lamina propria, but not to mucosal cells. Although provocative, it remains to be deter-
mined whether the probes interacting with lamina propria cells are hybridizing with
authentic mRNA for these receptors, whether these receptors are expressed on and regu-
late paracrine function ofthese immunocytes and whether any released transmitters in fact
modulate mucosal paracrine or exocrine cell function. Further studies are needed to deter-
mine the physiologic significance ofthese positive findings. However, there is little ques-
tion that the negative findings (the lack ofgastrin, cholinergic and histamine receptors on
exocrine and endocrine mucosal cells) are not true negatives, but rather reflect the relative
insensitivity ofthe in situ hybridization methods as utilized in these studies [16]. The con-
cept that the receptors regulating acid secretion are present on multiple cell types is con-
sistent with data from numerous investigators indicating that the regulation of acid secre-
tion reflects a complex paracrine/exocrine interaction involving several mucosal cells. It
is also quite possible that lamina propria cells modulate mucosal cell function; one exam-
ple is that macrophages are a major source ofmucosal prostaglandin production [17]. It is
likely that lamina propria cells are involved in the crosstalk regulating secretory function;
however, the absence of mucosal paracrine and exocrine cells in this conversation seem
quite unlikely.
THE RATIONALE FOR REDUNDANCY
Why does such redundancy exist in the pathways regulating acid secretion? Most
likely the consequences ofacid hypersecretion orhyposecretion from a standpoint ofphy-
logeny are sufficiently deleterious to dictate overlapping circuits to maximize the relia-
bility of the physiologic regulation. We surmise that the multiple gastrin/CCK and mus-
carinic receptors on parietal cells, histamine-ECL cells and somatostatin cells will each
demonstrate effects of physiologic or pathophysiologic importance. Critical processes
such as the regulation of acid secretion and the maintenance ofmucosal integrity appar-
ently require redundant control circuits. A challenge confronting future investigation will
be to sort out the physiologic or pathophysiologic settings in which each of these recep-
tors impacts regulatory processes.
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Sorting out the relevance of these redundant receptors mediating stimulatory and
inhibitory pathways involved in secretory regulation will be challenging, particularly
since these receptors may produce opposing effects on cell function. Examples include
prostaglandins, adenosine and cholinergic agents acting on somatostatin and G cells [3].
It likely that some of these responses are down- or up-regulated in vivo, but the mecha-
nisms and physiology ofsuch regulation remains to be defined. At this point, these oppos-
ing actions simply create confusion as one attempts to extrapolate from in vitro findings
to in vivo physiology and pathophysiology.
The models and approaches used to unravel the mysteries ofacid secretory regulation
will continue to evolve, but the concept that the pathways mediating acid secretion both
converge in parallel at the parietal cell and act in series, by modulating the release ofstim-
ulatory (histamine) and inhibitory (somatostatin) paracrine transmitters, remains an attrac-
tive hypothesis
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